Bio-Rad Laboratories Reports Q1 Earnings Amid Middle East Conflict Impact

Bio-Rad Laboratories reported a decline in Q1 net sales, citing reduced demand due to geopolitical tensions in the Middle East. The company revised its full-year revenue outlook downward and highlighted potential headwinds from ongoing conflicts.

By MarketBeat May 1, 2026 9 min read · Yahoo Finance · May 1, 2026, 06:05 UTC

Bio-Rad Laboratories Reports Q1 Earnings Amid Middle East Conflict Impact

Tickers: $BIO $GLW

Topics: diagnostics earnings geopolitical_impact M&A revenue_guidance

Read the full article at Yahoo Finance

More World news

IRS Announces Increased 401(k) Contribution Limits for 2027 CNBC · November 12, 2026, 17:23 UTC
Bit Digital Announces $865 Million Contract and Commencement of 40MW Billing Seeking Alpha · November 12, 2026, 17:20 UTC
Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC
Moderna Shares Decline Following Analyst Day Projections and Future Cost Concerns Motley Fool · November 12, 2026, 17:13 UTC
United Airlines Restricts AI Agent Access to Booking Systems Due to Cybersecurity and Regulatory Concerns TechCrunch · November 12, 2026, 17:17 UTC
Global Payments Shares Drop 12% Following Reports Private Equity Firms Abandoned Takeover Bid Seeking Alpha · November 12, 2026, 17:14 UTC
Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC